Heather Han

787 total citations
11 papers, 381 citations indexed

About

Heather Han is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heather Han has authored 11 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heather Han's work include HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers) and Medical Imaging Techniques and Applications (2 papers). Heather Han is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers) and Medical Imaging Techniques and Applications (2 papers). Heather Han collaborates with scholars based in United States, Spain and France. Heather Han's co-authors include Andres Forero‐Torres, Roohi Ismail‐Khan, Kevin E. Kip, C R Paterson, Manolete S. Moscoso, Pinky Budhrani-Shani, Sophia Ramesar, Richard R. Reich, Carissa B. Alinat and Cecile A. Lengacher and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Heather Han

11 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Han United States 7 289 152 64 62 46 11 381
Yaotiao Deng China 13 188 0.7× 58 0.4× 36 0.6× 70 1.1× 87 1.9× 35 435
Raymond Lord United States 5 145 0.5× 95 0.6× 28 0.4× 28 0.5× 28 0.6× 8 265
Rachel E. Lerner United States 11 123 0.4× 94 0.6× 21 0.3× 23 0.4× 54 1.2× 17 339
Aaron Chapman United States 7 182 0.6× 182 1.2× 82 1.3× 32 0.5× 174 3.8× 9 434
Ágnes Ruzsa Hungary 6 167 0.6× 115 0.8× 27 0.4× 37 0.6× 62 1.3× 9 301
S.Y. Chui United States 7 306 1.1× 132 0.9× 110 1.7× 79 1.3× 58 1.3× 8 426
Giovanni Iodice Italy 9 273 0.9× 135 0.9× 141 2.2× 8 0.1× 49 1.1× 19 499
Clizia Zichi Italy 12 140 0.5× 140 0.9× 47 0.7× 18 0.3× 62 1.3× 38 432
Jennifer Woodard United States 10 121 0.4× 44 0.3× 88 1.4× 75 1.2× 211 4.6× 34 502
Shiao‐Pei Weathers United States 8 100 0.3× 54 0.4× 32 0.5× 42 0.7× 60 1.3× 47 243

Countries citing papers authored by Heather Han

Since Specialization
Citations

This map shows the geographic impact of Heather Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Han more than expected).

Fields of papers citing papers by Heather Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Han. The network helps show where Heather Han may publish in the future.

Co-authorship network of co-authors of Heather Han

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Han. A scholar is included among the top collaborators of Heather Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Han. Heather Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Mills, Matthew N., Nicholas Figura, Peter Forsyth, et al.. (2020). Clinical Outcomes of Breast Cancer Brain Metastases Treated with Stereotactic Radiation and Capecitabine. International Journal of Radiation Oncology*Biology*Physics. 108(3). e685–e686. 1 indexed citations
3.
Mariotti, Veronica, Amrita Basu, Krithika N. Kodumudi, et al.. (2020). Strategies to Combat Human Epidermal Growth Factor Receptor 2 (HER2) Resistance in HER2-Positive Breast Cancer. Critical Reviews™ in Oncogenesis. 25(3). 209–231. 1 indexed citations
4.
Dièras, Véronique, Heather Han, Bella Kaufman, et al.. (2019). Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer. Annals of Oncology. 30. v857–v858. 23 indexed citations
5.
Figura, Nicholas, Michael Yu, Timothy J. Robinson, et al.. (2018). Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience. Breast Cancer Research and Treatment. 169(2). 391–396. 27 indexed citations
6.
Forero‐Torres, Andres, Heather Han, Elizabeth Claire Dees, et al.. (2018). Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009).. Journal of Clinical Oncology. 36(15_suppl). 1040–1040. 12 indexed citations
7.
Ahmed, Kamran A., G. Daniel Grass, Casey Liveringhouse, et al.. (2018). Personalizing Radiation Treatment Delivery in the Management of Breast Cancer. International Journal of Breast Cancer. 2018. 1–8. 10 indexed citations
8.
Nanda, Rita, Minetta C. Liu, Christina Yau, et al.. (2017). Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.. Journal of Clinical Oncology. 35(15_suppl). 506–506. 158 indexed citations
9.
Reich, Richard R., Cecile A. Lengacher, Carissa B. Alinat, et al.. (2016). Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters. Journal of Pain and Symptom Management. 53(1). 85–95. 134 indexed citations
10.
Jackson, Erica L., Susan Minton, Roohi Ismail‐Khan, et al.. (2012). A phase I study of 1-methyl-D-tryptophan in combination with docetaxel in metastatic solid tumors.. Journal of Clinical Oncology. 30(15_suppl). TPS2620–TPS2620. 4 indexed citations
11.
Pistilli, Barbara, Ander Urruticoechea, Heather Han, et al.. (2012). Ph Ib/Ii Study Of BKM120 Plus Trastuzumab (T) in Patients With T-resistant HER2+ Advanced Breast Cancer (BC). Annals of Oncology. 23. ix116–ix116. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026